Nebula Research & Development LLC Glaukos Corp Transaction History
Nebula Research & Development LLC
- $836 Billion
- Q3 2024
Shares
1 transactions
Others Institutions Holding GKOS
# of Institutions
340Shares Held
47.1MCall Options Held
132KPut Options Held
188K-
Black Rock Inc. New York, NY8.04MShares$1.16 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.87MShares$846 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA2.18MShares$314 Million0.05% of portfolio
-
State Street Corp Boston, MA1.95MShares$281 Million0.01% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN1.64MShares$236 Million0.06% of portfolio
About GLAUKOS Corp
- Ticker GKOS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,596,900
- Market Cap $6.85B
- Description
- Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...